Megaforce Company Limited (TPEX:3294)
Taiwan · Delayed Price · Currency is TWD 29.90
+0.05 (0.17%)
Sep 8, 2026, 11:56 AM CST
Megaforce Company Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,439 | 3,569 | 4,313 | 4,138 | 4,835 | 5,320 |
Revenue Growth | -11.38% | -17.24% | 4.21% | -14.41% | -9.11% | 4.44% |
Gross Profit Gross Profit Growth | 480.09 | 517.93 | 669.67 | 557.95 | 483.22 | 626.21 |
Operating Income Operating Income Growth | -108.89 | -63.14 | 34.72 | -46.45 | -84.88 | 45.02 |
Net Income Net Income Growth | 0.58 | -64.38 | 75.62 | -129.39 | -156.57 | 23.99 |
Earnings Per Share EPS Growth | 0.00 | -0.49 | 0.57 | -1.00 | -1.20 | 0.18 |
EPS Growth | - | - | - | - | - | -71.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Development of AI Applications Development of AI Applications Growth | 3.9 | 19.59 | 164.34 | - | 35.51 | - |
Optoelectronics Development Business Optoelectronics Development Business Growth | 26.21 | 17.06 | 1.3 | - | 10.9 | 0.47 |
Precision Manufacturing Electronics Business Precision Manufacturing Electronics Business Growth | 3,109 | 3,246 | 3,907 | 3,855 | 4,693 | - |
Fortis Biosolutions Business Fortis Biosolutions Business Growth | 47.45 | 55.47 | 7.6 | - | - | - |
Adjustments and Eliminations Adjustments and Eliminations Growth | -3.05 | -4.88 | -4.45 | -6.68 | -7.41 | -0.02 |
Biomedical and System Integration Business (Excluding Fortis Biosolutions Business) Biomedical and System Integration Business (Excluding Fortis Biosolutions Business) Growth | - | 236.2 | 236.35 | - | - | - |
Total Total Growth | 3,439 | 3,569 | 4,313 | 4,138 | 4,835 | 5,320 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,119 | 1,809 | 2,116 | 2,353 | 1,761 | 1,844 |
Total Debt Total Debt Growth | 1,134 | 995.82 | 931.03 | 1,408 | 1,687 | 1,925 |
Net Cash (Debt) Net Cash Growth | 984.91 | 813.24 | 1,185 | 944.92 | 74.68 | -80.9 |
Net Cash Growth | 3.65% | -31.39% | 25.44% | 1165.22% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 7.46 | 6.16 | 9.00 | 7.27 | 0.57 | -0.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 330.35 | 74.93 | 204.87 | 380.29 | 324.49 | 239.46 |
Capital Expenditures CapEx Growth | -268.92 | -101.34 | -42.54 | -47.58 | -75.7 | -166.91 |
Free Cash Flow Free Cash Flow Growth | 61.43 | -26.41 | 162.33 | 332.71 | 248.79 | 72.55 |
Free Cash Flow Growth | 3589.43% | - | -51.21% | 33.73% | 242.92% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 13.96% | 14.51% | 15.53% | 13.48% | 9.99% | 11.77% |
Operating Margin | -3.17% | -1.77% | 0.80% | -1.12% | -1.76% | 0.85% |
Pretax Margin | 1.79% | 0.09% | 3.41% | -0.18% | -0.31% | 1.45% |
Profit Margin | 0.02% | -1.80% | 1.75% | -3.13% | -3.24% | 0.45% |
FCF Margin | 1.79% | -0.74% | 3.76% | 8.04% | 5.15% | 1.36% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.380 | - | - | 0.250 |
Dividend Per Share Growth | - | - | - | -50.00% |
Dividend Yield | 1.14% | - | - | 0.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6770.92 | - | 58.92 | - | - | 166.99 |
P/FCF Ratio | 64.15 | - | 27.45 | 7.54 | 8.86 | 55.23 |
PS Ratio | 1.15 | 1.41 | 1.03 | 0.61 | 0.46 | 0.75 |